PNGM — Er Therapeutics Balance Sheet
0.000.00%
Basic MaterialsHighly SpeculativeMicro Cap
- $0.00m
- $0.26m
Annual balance sheet for Er Therapeutics, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2006 November 30th | 2007 November 30th | C2008 November 30th | C2009 November 30th | 2010 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10KSB | 10KSB | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.096 | 0.004 | 0.03 | 0.004 | 0 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.104 | 0.004 | 0.03 | 0.004 | 0 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.006 | 0.008 | 0.001 | 0.44 | 0.413 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.11 | 0.012 | 0.141 | 0.454 | 0.424 |
Accounts Payable | |||||
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.001 | 0.011 | 0.2 | 0.375 | 0.536 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.001 | 0.011 | 0.2 | 0.375 | 0.536 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.109 | 0 | -0.059 | 0.079 | -0.112 |
Total Liabilities & Shareholders' Equity | 0.11 | 0.011 | 0.141 | 0.454 | 0.424 |
Total Common Shares Outstanding |